"Dermatomyositis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
Descriptor ID |
D003882
|
MeSH Number(s) |
C05.651.594.819.500 C10.668.491.562.575.500 C17.300.250 C17.800.185
|
Concept/Terms |
Dermatomyositis- Dermatomyositis
- Dermatomyositides
- Juvenile Myositis
- Juvenile Myositides
- Myositides, Juvenile
- Myositis, Juvenile
- Dermatopolymyositis
- Dermatopolymyositides
- Polymyositis-Dermatomyositis
- Polymyositis Dermatomyositis
- Polymyositis-Dermatomyositides
- Juvenile Dermatomyositis
- Dermatomyositides, Juvenile
- Dermatomyositis, Juvenile
- Juvenile Dermatomyositides
Dermatomyositis, Adult Type- Dermatomyositis, Adult Type
- Adult Type Dermatomyositides
- Adult Type Dermatomyositis
- Dermatomyositides, Adult Type
Dermatomyositis, Childhood Type- Dermatomyositis, Childhood Type
- Childhood Type Dermatomyositides
- Childhood Type Dermatomyositis
- Dermatomyositides, Childhood Type
|
Below are MeSH descriptors whose meaning is more general than "Dermatomyositis".
Below are MeSH descriptors whose meaning is more specific than "Dermatomyositis".
This graph shows the total number of publications written about "Dermatomyositis" by people in this website by year, and whether "Dermatomyositis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 1 | 2 |
1999 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 4 | 0 | 4 |
2009 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
2019 | 0 | 1 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dermatomyositis" by people in Profiles.
-
A Retrospective Review of Tofacitinib in the Treatment of Refractory Dermatomyositis. J Drugs Dermatol. 2022 Oct 01; 21(10):1133-1134.
-
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195.
-
Fosaprepitant for the Management of Refractory Pain in a Patient with Cancer-Related Dermatomyositis. J Palliat Med. 2017 12; 20(12):1415-1419.
-
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. Pediatr Rheumatol Online J. 2017 Jun 13; 15(1):50.
-
Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol. 2013 Sep-Oct; 31(5):767-9.
-
Autoantibody testing for autoimmune disease. Clin Chest Med. 2010 Sep; 31(3):415-22.
-
The differential effect of child age on the illness intrusiveness--parent distress relationship in juvenile rheumatic disease. Rehabil Psychol. 2009 Feb; 54(1):45-50.
-
Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheum. 2008 Dec; 58(12):3941-50.
-
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum. 2008 Oct; 58(10):3239-46.
-
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore). 2008 Mar; 87(2):70-86.